Exogene Ltd.
Muhammad Hasan has diverse work experience in the research and development field. Muhammad currently holds the position of Director of R&D at Exogene Ltd. since March 2023. Previously, they served as a Senior Protein Scientist at the same company from July 2022 to March 2023. Prior to joining Exogene Ltd., Muhammad worked as a Postdoctoral Researcher at the University of Warwick from November 2016 to July 2022. Muhammad also gained experience as a Postdoctoral Scientist at Vrije Universiteit Brussel from May 2016 to November 2016.
Muhammad Hasan completed their education with a Bachelor of Arts degree in Mathematics from the University of Oxford, which they attended from 2004 to 2007. Following this, they pursued further study at the University of Warwick, where they obtained their Doctor of Philosophy (PhD) in Mathematical Biology and Biophysical Chemistry between 2011 and 2015.
This person is not in any teams
Exogene Ltd.
Exogene is a biotechnology company accelerating the discovery of T-cell-receptor(TCR)-based cancer immunotherapies for solid tumours by combining deep learning and high-throughput TCR-antigen screening. Exogene is building a computational platform to quickly and inexpensively identify new tumour targets shared across cancer patients, as well assafe and effective TCRs against these tumour targets for therapeutic application. Their mission is to develop better TCR-based immunotherapies, faster and at a fraction of the cost.